共 50 条
High-flow nasal oxygen therapy and hypercapnic acute respiratory failure
被引:0
作者:
Girault, C.
[1
]
Artaud-Macari, E.
[2
]
Jolly, G.
[3
]
Carpentier, D.
[3
]
Cuvelier, A.
[2
]
Beduneau, G.
[1
]
机构:
[1] Normandie Univ, CHU Rouen, Hop Rouen, GRHVN UR 3830,Serv Med Intens & Reanimat, F-76000 Rouen, France
[2] Normandie univ, CHU Rouen, Hop Rouen, GRHVN UR 3830,Serv Pneumol Oncol Thorac & Soins I, F-76000 Rouen, France
[3] CHU Rouen, Hop Rouen, Serv Med Intens & Reanimat, F-76000 Rouen, France
关键词:
Acute respiratory failure;
Hypercapnia;
High-flow nasal oxygen therapy;
Non-invasive ventilation;
Chronic obstructive pulmonary disease;
Extubation;
OBSTRUCTIVE PULMONARY-DISEASE;
POSITIVE-PRESSURE VENTILATION;
ANATOMICAL DEAD SPACE;
NONINVASIVE VENTILATION;
CANNULA;
EXACERBATIONS;
MECHANISMS;
SUPPORT;
AIR;
D O I:
10.1016/j.rmr.2024.06.002
中图分类号:
R56 [呼吸系及胸部疾病];
学科分类号:
摘要:
Humidified high-flow nasal oxygen therapy (HFNO) has, in recent years, come to assume a key role in the management of hypoxemic acute respiratory failure (ARF). While non-invasive ventilation (NIV) currently represents the first-line ventilatory strategy in patients exhibiting hypercapnic ARF, the operating principles and physiological effects of HFNO could be interesting and useful in the initial management of hypercapnic ARF and/or after extubation, particularly in acute exacerbations of chronic obstructive pulmonary disease. Under these conditions, HFNO could be used either alone continuously or in combination with NIV during breaks in spontaneous breathing, depending on the severity and etiology of the underlying hypercapnic ARF. (c) 2024 SPLF. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:498 / 507
页数:10
相关论文
共 50 条